139 related articles for article (PubMed ID: 9808054)
21. The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma.
Schneider EM; Torlakovic E; Stühler A; Diehl V; Tesch H; Giebel B
J Pathol; 2004 Dec; 204(5):538-45. PubMed ID: 15538755
[TBL] [Abstract][Full Text] [Related]
22. Activation of the erythropoietin receptor promoter by transcription factor GATA-1.
Zon LI; Youssoufian H; Mather C; Lodish HF; Orkin SH
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10638-41. PubMed ID: 1660143
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiation.
Ikonomi P; Rivera CE; Riordan M; Washington G; Schechter AN; Noguchi CT
Exp Hematol; 2000 Dec; 28(12):1423-31. PubMed ID: 11146164
[TBL] [Abstract][Full Text] [Related]
24. Regulation of transcription of the human erythropoietin receptor gene by proteins binding to GATA-1 and Sp1 motifs.
Chin K; Oda N; Shen K; Noguchi CT
Nucleic Acids Res; 1995 Aug; 23(15):3041-9. PubMed ID: 7659529
[TBL] [Abstract][Full Text] [Related]
25. Cre recombinase expression controlled by the hematopoietic regulatory domain of Gata-1 is erythroid-specific.
Yoon D; Kim B; Prchal JT
Blood Cells Mol Dis; 2008; 40(3):381-7. PubMed ID: 18077194
[TBL] [Abstract][Full Text] [Related]
26. GATA and NF-Y participate in transcriptional regulation of FcgammaRIIA in megakaryocytic cells.
Cassel DL; Subudhi SK; Surrey S; McKenzie SE
Blood Cells Mol Dis; 2000 Dec; 26(6):587-97. PubMed ID: 11112392
[TBL] [Abstract][Full Text] [Related]
27. Cell-cycle-dependent regulation of erythropoietin receptor gene.
Komatsu N; Kirito K; Kashii Y; Furukawa Y; Kikuchi J; Suwabe N; Yamamoto M; Miura Y
Blood; 1997 Feb; 89(4):1182-8. PubMed ID: 9028940
[TBL] [Abstract][Full Text] [Related]
28. Reversal of tumorigenicity and the block to differentiation in erythroleukemia cells by GATA-1.
Choe KS; Radparvar F; Matushansky I; Rekhtman N; Han X; Skoultchi AI
Cancer Res; 2003 Oct; 63(19):6363-9. PubMed ID: 14559825
[TBL] [Abstract][Full Text] [Related]
29. Expression pattern of WT1 and GATA-1 in AML with chromosome 16q22 abnormalities.
Patmasiriwat P; Fraizer GC; Claxton D; Kantarjian H; Saunders GF
Leukemia; 1996 Jul; 10(7):1127-33. PubMed ID: 8683991
[TBL] [Abstract][Full Text] [Related]
30. E2F and GATA-1 are required for the Sertoli cell-specific promoter activity of the follicle-stimulating hormone receptor gene.
Kim JS; Griswold MD
J Androl; 2001; 22(4):629-39. PubMed ID: 11451360
[TBL] [Abstract][Full Text] [Related]
31. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression.
Arcasoy MO; Maun NA; Perez L; Forget BG; Berliner N
Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594
[TBL] [Abstract][Full Text] [Related]
32. Transactivation of erythroid transcription factor GATA-1 by a myb-ets-containing retrovirus.
Aurigemma RE; Blair DG; Ruscetti SK
J Virol; 1992 May; 66(5):3056-61. PubMed ID: 1560536
[TBL] [Abstract][Full Text] [Related]
33. Expression of GATA-2 in human pituitary adenomas.
Umeoka K; Sanno N; Osamura RY; Teramoto A
Mod Pathol; 2002 Jan; 15(1):11-7. PubMed ID: 11796836
[TBL] [Abstract][Full Text] [Related]
34. GATA-1 transactivates erythropoietin receptor gene, and erythropoietin receptor-mediated signals enhance GATA-1 gene expression.
Chiba T; Ikawa Y; Todokoro K
Nucleic Acids Res; 1991 Jul; 19(14):3843-8. PubMed ID: 1650452
[TBL] [Abstract][Full Text] [Related]
35. Constitutive expression of GATA-1, EPOR, alpha-globin, and gamma-globin genes in myeloid clonogenic cells from juvenile chronic myelocytic leukemia.
Privitera E; Schirò R; Longoni D; Ronchi A; Rambaldi A; Bernasconi S; Ottolenghi S; Masera G; Biondi A
Blood; 1995 Jul; 86(1):323-8. PubMed ID: 7795240
[TBL] [Abstract][Full Text] [Related]
36. A structurally abnormal erythropoietin receptor gene in a human erythroleukemia cell line.
Ward JC; Harris KW; Penny LA; Forget BG; Kitamura T; Winkelmann JC
Exp Hematol; 1992 Mar; 20(3):371-3. PubMed ID: 1314735
[TBL] [Abstract][Full Text] [Related]
37. Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface.
Migliaccio AR; Migliaccio G; D'Andrea A; Baiocchi M; Crotta S; Nicolis S; Ottolenghi S; Adamson JW
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11086-90. PubMed ID: 1722318
[TBL] [Abstract][Full Text] [Related]
38. Further characterization of cis-acting regulatory sequences in the genomic locus of the murine erythropoietin receptor: evidence for stage-specific regulation.
Youssoufian H
Blood; 1994 Mar; 83(5):1428-35. PubMed ID: 8118044
[TBL] [Abstract][Full Text] [Related]
39. Expression of c-MYC under the control of GATA-1 regulatory sequences causes erythroleukemia in transgenic mice.
Skoda RC; Tsai SF; Orkin SH; Leder P
J Exp Med; 1995 May; 181(5):1603-13. PubMed ID: 7722440
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of GATA-1 expression during phorbol myristate acetate-induced megakaryocytic differentiation of human erythroleukemia cells.
Dai W; Murphy MJ
Blood; 1993 Mar; 81(5):1214-21. PubMed ID: 8443382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
